Figure 1.
Proportion of rituximab responders in relation to FCGR3A genotype in RA patients. Significant differences are indicated as *p<0.05, **p<0.01.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.